"Gastrointestinal toxicities tended to occur early after treatment initiation with fluctuation over time, both in a type 2 diabetic population and a more general population." Lulu Liu, Researcher, West China Second University Hospital Theres a noticeable difference between short-acting and long-acting formulations
A) Our program includes FDA-approved and off-label medication options that may include GLP-1, GIP, or combination GLP-1/GIP therapies
The real concern is the underlying insulin resistance, she said, which puts people at risk for a whole range of conditions including high blood pressure, heart, kidney and liver disease and certain forms of cancer. Addiction and substance use
However, our natural glutathione levels can decline as we age, leaving us more susceptible to oxidative stress and inflammation